KLRC2 and cancer: To achieve this, we examined the transcriptomic profiles of nearly 400,000 CD8+ T cells from 21 cancer types (Figure 4D) and assigned them as NKG2A+, NKG2C+, or neither based on mRNA expression levels (see STAR Methods).